Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure.

Bosserman EA, Helms DJ, Mosure DJ, Secor WE, Workowski KA.

Sex Transm Dis. 2011 Oct;38(10):983-7. doi: 10.1097/OLQ.0b013e318224db39.

PMID:
21934577
2.

Sexually transmitted diseases treatment guidelines, 2010.

Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC)..

MMWR Recomm Rep. 2010 Dec 17;59(RR-12):1-110. Erratum in: MMWR Recomm Rep. 2011 Jan 14;60(1):18. Dosage error in article text.

3.

Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.

Krashin JW, Koumans EH, Bradshaw-Sydnor AC, Braxton JR, Evan Secor W, Sawyer MK, Markowitz LE.

Sex Transm Dis. 2010 Jul;37(7):440-4. doi: 10.1097/OLQ.0b013e3181cfcd8c.

PMID:
20351623
4.

Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea.

Upcroft JA, Dunn LA, Wal T, Tabrizi S, Delgadillo-Correa MG, Johnson PJ, Garland S, Siba P, Upcroft P.

Sex Health. 2009 Dec;6(4):334-8. doi: 10.1071/SH09011.

PMID:
19917203
5.

The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L.

Clin Infect Dis. 2007 Nov 15;45(10):1319-26. Epub 2007 Oct 15.

PMID:
17968828
6.

Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM.

J Infect Dis. 2007 Mar 1;195(5):698-702. Epub 2007 Jan 22.

PMID:
17262712
7.

Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.

Schwebke JR, Barrientes FJ.

Antimicrob Agents Chemother. 2006 Dec;50(12):4209-10. Epub 2006 Sep 25.

8.

Treatment failure of vaginal trichomoniasis in clinical practice.

Das S, Huengsberg M, Shahmanesh M.

Int J STD AIDS. 2005 Apr;16(4):284-6.

PMID:
15899079
9.

Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000.

Weinstock H, Berman S, Cates W Jr.

Perspect Sex Reprod Health. 2004 Jan-Feb;36(1):6-10.

PMID:
14982671
10.

In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.

Crowell AL, Sanders-Lewis KA, Secor WE.

Antimicrob Agents Chemother. 2003 Apr;47(4):1407-9.

11.

Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.

Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm AW.

Clin Infect Dis. 2002 Feb 15;34(4):519-22. Epub 2002 Jan 7.

PMID:
11797180
12.

Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.

Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H.

J Reprod Med. 2001 Jun;46(6):545-9.

PMID:
11441678
13.

Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.

Pérez S, Fernández-Verdugo A, Pérez F, Vázquez F.

Sex Transm Dis. 2001 Feb;28(2):115-6. No abstract available.

PMID:
11234785
14.

Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.

Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, Krohn MA, Klebanoff MA, Rao AV, Rhoads GG.

Sex Transm Dis. 1997 Jul;24(6):353-60.

PMID:
9243743
15.

Risk factors for prematurity and premature rupture of membranes: a prospective study of the vaginal flora in pregnancy.

Minkoff H, Grunebaum AN, Schwarz RH, Feldman J, Cummings M, Crombleholme W, Clark L, Pringle G, McCormack WM.

Am J Obstet Gynecol. 1984 Dec 15;150(8):965-72.

PMID:
6391179
16.
17.
18.

Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.

Meingassner JG, Thurner J.

Antimicrob Agents Chemother. 1979 Feb;15(2):254-7.

Supplemental Content

Support Center